Argus upgrades Integra to Buy, says well-positioned for a turnaround
Argus analyst David Toung upgraded Integra LifeSciences (IART) to Buy from Hold with a $28 price target The firm sees the ...
TipRanks on MSN1 个月
Bio-Techne price target lowered to $90 from $95 at Argus
Argus analyst David Toung lowered the firm’s price target on Bio-Techne (TECH) to $90 from $95 and keeps a Buy rating on the ...